IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: It is considered that DMR can be maintained by the combination of the two-way action of IFN-<i>α</i>, that is, the transfer of dormant CML stem cells to the cellcycle and the activation of a specific immune response to CML cells.